Sight Sciences is an American ophthalmic medical device company that engages the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It was incorporated in 2010 and is headquartered in Menlo Park, California.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Sight Sciences news
11.05.2022
Sight Sciences reported a GAAP loss of $23.263 million for 3 months of 2022, up 90.1% from $12.24 million in the previous year. Revenue increased 72.3% to $14.881 million from $8.635 million a year earlier.
Source: 
investors.sightsciences.com
investors.sightsciences.com
25.03.2022
Sight Sciences' GAAP loss for 2021 was $62.96 million, up 81.5% from $34.693 million in the previous year. Revenue increased 77.1% to $48.956 million from $27.64 million a year earlier.
Source: investors.sightsciences.com
investors.sightsciences.com
11.11.2021
Sight Sciences' GAAP loss for 9M 2021 was $47.024 million, up 83.8% from $25.588 million in the prior year. Revenue increased 83.8% to $34.271 million from $18.649 million a year earlier.
Source: investors.sightsciences.com
investors.sightsciences.com
General information
| Company name | Sight Sciences |
|---|---|
| Tags | #ophthalmology, #medical equipment |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
| Business address | 4040 Campbell Avenue Suite 100 Menlo Park, CA 94025 United States |
| Mailing address | 4040 Campbell Avenue Suite 100 Menlo Park, CA 94025 United States |
| Website | investors.sightsciences.com |
English (US) 